BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

681 related articles for article (PubMed ID: 21062666)

  • 1. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial.
    Dondorp AM; Fanello CI; Hendriksen IC; Gomes E; Seni A; Chhaganlal KD; Bojang K; Olaosebikan R; Anunobi N; Maitland K; Kivaya E; Agbenyega T; Nguah SB; Evans J; Gesase S; Kahabuka C; Mtove G; Nadjm B; Deen J; Mwanga-Amumpaire J; Nansumba M; Karema C; Umulisa N; Uwimana A; Mokuolu OA; Adedoyin OT; Johnson WB; Tshefu AK; Onyamboko MA; Sakulthaew T; Ngum WP; Silamut K; Stepniewska K; Woodrow CJ; Bethell D; Wills B; Oneko M; Peto TE; von Seidlein L; Day NP; White NJ;
    Lancet; 2010 Nov; 376(9753):1647-57. PubMed ID: 21062666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial.
    Dondorp A; Nosten F; Stepniewska K; Day N; White N;
    Lancet; 2005 Aug 27-Sep 2; 366(9487):717-25. PubMed ID: 16125588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artemether for severe malaria.
    Esu E; Effa EE; Opie ON; Uwaoma A; Meremikwu MM
    Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD010678. PubMed ID: 25209020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-treatment haemolysis in African children with hyperparasitaemic falciparum malaria; a randomized comparison of artesunate and quinine.
    Fanello C; Onyamboko M; Lee SJ; Woodrow C; Setaphan S; Chotivanich K; Buffet P; Jauréguiberry S; Rockett K; Stepniewska K; Day NPJ; White NJ; Dondorp AM
    BMC Infect Dis; 2017 Aug; 17(1):575. PubMed ID: 28818049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of artesunate and quinine in the treatment of severe Plasmodium falciparum malaria at Kassala hospital, Sudan.
    Abdallah TM; Elmardi KA; Elhassan AH; Omer MB; Elhag MS; Desogi MA; Siddig MF; Adam I
    J Infect Dev Ctries; 2014 May; 8(5):611-5. PubMed ID: 24820465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artemether for severe malaria.
    Esu EB; Effa EE; Opie ON; Meremikwu MM
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD010678. PubMed ID: 31210357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artesunate-clindamycin versus quinine-clindamycin in the treatment of Plasmodium falciparum malaria: a randomized controlled trial.
    Ramharter M; Oyakhirome S; Klein Klouwenberg P; Adégnika AA; Agnandji ST; Missinou MA; Matsiégui PB; Mordmüller B; Borrmann S; Kun JF; Lell B; Krishna S; Graninger W; Issifou S; Kremsner PG
    Clin Infect Dis; 2005 Jun; 40(12):1777-84. PubMed ID: 15909266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
    West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
    Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of re-treatment with the same artemisinin-based combination treatment (ACT) compared with an alternative ACT and quinine plus clindamycin after failure of first-line recommended ACT (QUINACT): a bicentre, open-label, phase 3, randomised controlled trial.
    Mavoko HM; Nabasumba C; da Luz RI; Tinto H; D'Alessandro U; Kambugu A; Baraka V; Rosanas-Urgell A; Lutumba P; Van Geertruyden JP
    Lancet Glob Health; 2017 Jan; 5(1):e60-e68. PubMed ID: 27840069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of severe paediatric malaria in resource-limited settings.
    Maitland K
    BMC Med; 2015 Mar; 13():42. PubMed ID: 25858094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of artesunate-mefloquine and artemether-lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial.
    Sirima SB; Ogutu B; Lusingu JPA; Mtoro A; Mrango Z; Ouedraogo A; Yaro JB; Onyango KO; Gesase S; Mnkande E; Ngocho JS; Ackermann I; Aubin F; Vanraes J; Strub N; Carn G
    Lancet Infect Dis; 2016 Oct; 16(10):1123-1133. PubMed ID: 27430374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosing severe falciparum malaria in parasitaemic African children: a prospective evaluation of plasma PfHRP2 measurement.
    Hendriksen IC; Mwanga-Amumpaire J; von Seidlein L; Mtove G; White LJ; Olaosebikan R; Lee SJ; Tshefu AK; Woodrow C; Amos B; Karema C; Saiwaew S; Maitland K; Gomes E; Pan-Ngum W; Gesase S; Silamut K; Reyburn H; Joseph S; Chotivanich K; Fanello CI; Day NP; White NJ; Dondorp AM
    PLoS Med; 2012; 9(8):e1001297. PubMed ID: 22927801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial.
    Smithuis F; Kyaw MK; Phe O; Win T; Aung PP; Oo AP; Naing AL; Nyo MY; Myint NZ; Imwong M; Ashley E; Lee SJ; White NJ
    Lancet Infect Dis; 2010 Oct; 10(10):673-81. PubMed ID: 20832366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artesunate versus quinine for treating severe malaria.
    Jones KL; Donegan S; Lalloo DG
    Cochrane Database Syst Rev; 2007 Oct; (4):CD005967. PubMed ID: 17943870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized comparison of artesunate and quinine in the treatment of severe falciparum malaria.
    Newton PN; Angus BJ; Chierakul W; Dondorp A; Ruangveerayuth R; Silamut K; Teerapong P; Suputtamongkol Y; Looareesuwan S; White NJ
    Clin Infect Dis; 2003 Jul; 37(1):7-16. PubMed ID: 12830403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No Reduction in Hemoglobin Level in Severe Plasmodium falciparum Malaria Treated with Artesunate in Central Sudan.
    Eltahir HG; Bilal JA; Ali EA; Adam I
    J Trop Pediatr; 2017 Feb; 63(1):18-22. PubMed ID: 27370816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piperaquine concentration and malaria treatment outcomes in Ugandan children treated for severe malaria with intravenous Artesunate or quinine plus Dihydroartemisinin-Piperaquine.
    Byakika-Kibwika P; Ssenyonga R; Lamorde M; Blessborn D; Tarning J
    BMC Infect Dis; 2019 Dec; 19(1):1025. PubMed ID: 31795967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous artesunate for severe malaria.
    Prescrire Int; 2008 Aug; 17(96):168-70. PubMed ID: 19492495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized control trial of quinine and artesunate in complicated malaria.
    Mohanty AK; Rath BK; Mohanty R; Samal AK; Mishra K
    Indian J Pediatr; 2004 Apr; 71(4):291-5. PubMed ID: 15107507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artesunate, artemether or quinine in severe Plasmodium falciparum malaria?
    Checkley AM; Whitty CJ
    Expert Rev Anti Infect Ther; 2007 Apr; 5(2):199-204. PubMed ID: 17402835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.